TiHKAL
Template:Short description Template:Distinguish Template:Use American English Template:Use mdy dates Template:Infobox book
TiHKAL: The Continuation, also known as Tryptamines I Have Known and Loved, is a 1997 book written by Alexander Shulgin and Ann Shulgin.<ref name="Sessa2015">Template:Cite book</ref><ref name="TiHKAL1997">Template:Cite book</ref> It is about a family of psychoactive drugs known as tryptamines, which includes psychedelics, other hallucinogens, and entactogens.<ref name="Sessa2015" /><ref name="TiHKAL1997" /> The book has two halves, and the second part of the book contains detailed entries on 55Template:Nbsptryptamines.<ref name="TiHKAL1997" /> TiHKAL is a sequel to PiHKAL: A Chemical Love Story (Phenethylamines I Have Known and Loved) (1991).<ref name="Sessa2015" /><ref name="TiHKAL1997" />
Content
TiHKAL, much like its predecessor PiHKAL, is divided into two parts.<ref name="TiHKAL1997" /> The first part, for which all rights are reserved, begins with a fictionalized autobiography, picking up where the similar section of PiHKAL left off; it then continues with a collection of essays on topics ranging from psychotherapy and the Jungian mind to the prevalence of DMT in nature, ayahuasca and the war on drugs.<ref name="TiHKAL1997" />
The second part of TiHKAL, which may be conditionally distributed for non-commercial reproduction Template:See below, is a detailed synthesis manual for 55Template:Nbsptryptamines (many discovered by Alexander Shulgin himself), including their chemical structures, doses, durations, and commentary.<ref name="TiHKAL1997" /> It includes entries on compounds including simple tryptamines like dimethyltryptamine (DMT), psilocin, and 5-MeO-DMT, α-alkyltryptamines like α-methyltryptamine (AMT), β-carbolines or harmala alkaloids like harmaline, the iboga alkaloid ibogaine, and lysergamides like LSD.<ref name="TiHKAL1997" /> Whereas PiHKAL had 179Template:Nbspentries on phenethylamines, TiHKAL has only 55Template:Nbspentries.<ref name="PiHKAL">Template:CitePiHKAL</ref><ref name="TiHKAL1997" /> Shulgin has made the second part freely available on Erowid while the first part is available only in the printed text.
Members of Shulgin's research who contributed to the experience reports included Shulgin himself, Ann Shulgin, Myron Stolaroff, and Jean Stolaroff, among others.<ref name="BLTC2021">Template:Cite AV media</ref><ref name="PassieBrandt2018">Template:Cite journal</ref>
Response
As with PiHKAL, the Shulgins were motivated to release the synthesis information as a way to protect the public's access to information about psychedelic compounds, a goal Alexander Shulgin has noted many times.<ref name="nyt"> Template:Cite news</ref> Following a raid of his laboratory in 1994 by the United States DEA,<ref> Template:Cite web</ref> Richard Meyer, spokesman for DEA's San Francisco Field Division, stated that "It is our opinion that those books [referring to the previous work, PiHKAL are pretty much cookbooks on how to make illegal drugs. Agents tell me that in clandestine labs that they have raided, they have found copies of those books."
Notable compounds
Some compounds in TiHKAL, including dimethyltryptamine (DMT), psilocybin (4-PO-DMT), psilocin (4-HO-DMT), bufotenin (5-HO-DMT), 5-MeO-DMT, α-methyltryptamine (AMT), lysergic acid diethylamide (LSD), harmaline, and ibogaine, are widely known and/or used hallucinogens.<ref name="TiHKAL1997" />
Tryptamines listed
| # | Substance | Chemical name | Group | Dosea | Duration | Link |
|---|---|---|---|---|---|---|
| 1 | AL-LAD (6-allyl-6-nor-LSD) | 6-Allyl-N,N-diethyl-NL | Lysergamide | 80–160 μg | 6–8 hours | [1] |
| 2 | DBT (dibutyltryptamine) | N,N-Dibutyl-T | Tryptamine | Unknown | Unknown | [2] |
| 3 | DET (diethyltryptamine) | N,N-Diethyl-T | Tryptamine | 50–100 mg | 2–4 hours | [3] |
| 4 | DiPT (diisopropyltryptamine) | N,N-Diisopropyl-T | Tryptamine | 25–100 mg | 6–8 hours | [4] |
| 5 | α,O-DMS (5-MeO-AMT) | 5-Methoxy-α-methyl-T | α-Alkyltryptamine | 2.5–4.5 mg | 12–18 hours | [5] |
| 6 | DMT (dimethyltryptamine) | N,N-Dimethyl-T | Tryptamine | Variousb | Up to 1 hour | [6] |
| 7 | 2,α-DMT (2-methyl-AMT) | 2,α-Dimethyl-T | α-Alkyltryptamine | 300–500 mg | 7–10 hours | [7] |
| 8 | α,N-DMT (N-methyl-AMT) | α,N-Dimethyl-T | α-Alkyltryptamine | 50–100 mg | 6–8 hours | [8] |
| 9 | DPT (dipropyltryptamine) | N,N-Dipropyl-T | Tryptamine | 100–250 mg | 2–4 hours | [9] |
| 10 | EiPT (ethylisopropyltryptamine) | N-Ethyl-N-isopropyl-T | Tryptamine | 24–40 mg | 4–6 hours | [10] |
| 11 | α-ET (AET; α-ethyltryptamine) | α-Ethyl-T | α-Alkyltryptamine | 100–150 mg | 6–8 hours | [11] |
| 12 | ETH-LAD (6-ethyl-6-nor-LSD) | 6,N,N-Triethyl-NL | Lysergamide | 40–150 μg | 8–12 hours | [12] |
| 13 | Harmaline (dihydroharmine) | 3,4-Dihydro-7-methoxy-1-methyl-BC | β-Carboline | 150–300 mg | 5–8 hours | [13] |
| 14 | Harmine | 7-Methyoxy-1-methyl-BC | β-Carboline | >300 mg | Unknown | [14] |
| 15 | 4-HO-DBT | N,N-Dibutyl-4-hydroxy-T | 4-Hydroxytryptamine | >20 mg | Unknown | [15] |
| 16 | 4-HO-DET | N,N-Diethyl-4-hydroxy-T | 4-Hydroxytryptamine | 10–25 mg | 4–6 hours | [16] |
| 17 | 4-HO-DiPT | N,N-Diisopropyl-4-hydroxy-T | 4-Hydroxytryptamine | 15–20 mg | 2–3 hours | [17] |
| 18 | 4-HO-DMT (psilocin) | N,N-Dimethyl-4-hydroxy-T | 4-Hydroxytryptamine | 10–20 mg | 3–6 hours | [18] |
| 19 | 5-HO-DMT (bufotenin) | N,N-Dimethyl-5-hydroxy-T | 5-Hydroxytryptamine | 8–16 mg Template:Abbr | 1–2 hours | [19] |
| 20 | 4-HO-DPT | N,N-Dipropyl-4-hydroxy-T | 4-Hydroxytryptamine | Unknown | Unknown | [20] |
| 21 | 4-HO-MET | N-Ethyl-4-hydroxy-N-methyl-T | 4-Hydroxytryptamine | 10–20 mg | 4–6 hours | [21] |
| 22 | 4-HO-MiPT | 4-Hydroxy-N-isopropyl-N-methyl-T | 4-Hydroxytryptamine | 12–25 mg | 4–6 hours | [22] |
| 23 | 4-HO-MPT | 4-Hydroxy-N-methyl-N-propyl-T | 4-Hydroxytryptamine | Unknown | Unknown | [23] |
| 24 | 4-HO-pyr-T | 4-Hydroxy-N,N-tetramethylene-T | Pyrrolidinylethylindole | >20 mg | Unknown | [24] |
| 25 | Ibogaine | A complexly substituted-T | Azepinoindole | Variousc | "Quite long" | [25] |
| 26 | LSD (METH-LAD) | N,N-Diethyl-L | Lysergamide | 60–200 μg | 8–12 hours | [26] |
| 27 | MBT (methylbutyltryptamine) | N-Butyl-N-methyl-T | Tryptamine | 250–400 mg | 4–6 hours | [27] |
| 28 | 4,5-MDO-DiPT | N,N-Diisopropyl-4,5-methylenedioxy-T | Other | >25 mg | Unknown | [28] |
| 29 | 5,6-MDO-DiPT | N,N-Diisopropyl-5,6-methylenedioxy-T | Other | Unknown | Unknown | [29] |
| 30 | 4,5-MDO-DMT | N,N-Dimethyl-4,5-methylenedioxy-T | Other | Unknown | Unknown | [30] |
| 31 | 5,6-MDO-DMT | N,N-Dimethyl-5,6-methylenedioxy-T | Other | >5 mg | Unknown | [31] |
| 32 | 5,6-MDO-MiPT | N-Isopropyl-N-methyl-5,6-methylenedioxy-T | Other | >50 mg | Unknown | [32] |
| 33 | 2-Me-DET (2-methyl-DET) | N,N-Diethyl-2-methyl-T | Other | 80–120 mg | 6–8 hours | [33] |
| 34 | 2-Me-DMT (2-methyl-DMT) | 2,N,N-Trimethyl-T | Other | 50–100 mg | 4–6 hours | [34] |
| 35 | Melatonin (5-MeO-NAcT) | N-Acetyl-5-methoxy-T | N-Acetyltryptamine | 1–10 mg | "A few hours" | [35] |
| 36 | 5-MeO-DET | N,N-Diethyl-5-methoxy-T | 5-Methoxytryptamine | 1–3 mg | 3–4 hours | [36] |
| 37 | 5-MeO-DiPT | N,N-Diisopropyl-5-methoxy-T | 5-Methoxytryptamine | 6–12 mg | 4–8 hours | [37] |
| 38 | 5-MeO-DMT | 5-Methoxy-N,N-dimethyl-T | 5-Methoxytryptamine | Variousd | 1–2 hours | [38] |
| 39 | 4-MeO-MiPT | N-Isopropyl-4-methoxy-N-methyl-T | Other | 20–30 mg | 4–6 hours | [39] |
| 40 | 5-MeO-MiPT | N-Isopropyl-5-methoxy-N-methyl-T | 5-Methoxytryptamine | 4–6 mge | 4–6 hours | [40] |
| 41 | 5,6-MeO-MiPT | 5,6-Dimethoxy-N-isopropyl-N-methyl-T | Other | >75 mg | Unknown | [41] |
| 42 | 5-MeO-NMT | 5-Methoxy-N-methyl-T | 5-Methoxytryptamine | Unknown | Unknown | [42] |
| 43 | 5-MeO-pyr-T | 5-Methoxy-N,N-tetramethylene-T | Pyrrolidinylethylindole | 0.5–2 mg | "Several hours" | [43] |
| 44 | 6-MeO-THH | 6-Methoxy-1-methyl-1,2,3,4-tetrahydro-BC | β-Carboline | Unknown | Unknown | [44] |
| 45 | 5-MeO-TMT | 5-Methoxy-2,N,N-trimethyl-T | Other | 75–150 mg | 5–10 hours | [45] |
| 46 | 5-MeS-DMT | N,N-Dimethyl-5-methylthio-T | Other | 15–30 mg Template:Abbr | <1 hour | [46] |
| 47 | MiPT (methylisopropyltryptamine) | N-Isopropyl-N-methyl-T | Tryptamine | 10–25 mg | 3–4 hours | [47] |
| 48 | α-MT (AMT; α-methyltryptamine) | α-Methyl-T | α-Alkyltryptamine | 15–30 mgf | 12–16 hours | [48] |
| 49 | NET (N-ethyltryptamine) | N-Ethyl-T | Tryptamine | Unknown | Unknown | [49] |
| 50 | NMT (N-methyltryptamine) | N-Methyl-T | Tryptamine | Unknown | Unknown | [50] |
| 51 | PRO-LAD (6-propyl-6-nor-LSD) | 6-Propyl-NL | Lysergamide | 100–200 μg | 6–8 hours | [51] |
| 52 | pyr-T (pyrrolidinyltryptamine) | N,N-Tetramethylene-T | Pyrrolidinylethylindole | Unknown | Unknown | [52] |
| 53 | T (tryptamine) | Tryptamine | Tryptamine | 250 mg Template:Abbr | "Very short" | [53] |
| 54 | Tetrahydroharmine (THH) | 7-Methoxy-1-methyl-1,2,3,4-tetrahydro-BC | β-Carboline | 300 mg | Unknown | [54] |
| 55 | α,N,O-TMS (5-MeO-α,N-DMT) | α,N-Dimethyl-5-methoxy-T | α-Alkyltryptamine | 10–20 mg | 6–8 hours | [55] |
| 56 | 5-MeO-DALTg | 5-Methoxy-N,N-diallyl-T | 5-Methoxytryptamine | 12–20 mg | 2–4 hours | [56] [57] |
| 57 | DALT (diallyltryptamine)g | N,N-Diallyl-T | Tryptamine | >40 mg | Unknown | [58] |
| Footnotes: a = Dose and duration are orally unless otherwise specified. b = DMT doses are >350Template:Nbspmg orally, 60–100Template:Nbspmg intramuscularly, subcutaneously, or smoked, and 4–30Template:Nbspmg intravenously. c = Ibogaine dose is "from hundreds of [mg] up to [1Template:Nbspg] or more". d = 5-MeO-DMT doses are 6–20Template:Nbspmg smoked and 2–3 mg intravenously. e = 5-MeO-MiPT doses are 4–6Template:Nbspmg orally and 12–20Template:Nbspmg smoked. f = AMT doses are 15–30 mg orally and 5–20 mg smoked. g = The 5-MeO-DALT (#56) and DALT (#57) entries were not included in the published version of TiHKAL and were subsequently released in 2004.<ref name="MorrisSmith2010">Template:Cite web</ref> | ||||||
See also
- Bibliography of Alexander Shulgin
- PiHKAL (Phenethylamines I Have Known and Loved) (1991)
- The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds (2011)
- List of psychedelic literature
- Substituted tryptamine
- Substituted β-carboline and harmala alkaloid
- Azepinoindole and iboga alkaloid
- Substituted lysergamide
References
External links
- Erowid Online Books: TiHKAL: The Continuation by Alexander & Ann Shulgin
- "Shulgin in Spanish" Project – Information on the first complete translation of PiHKAL and TiHKAL into Spanish
- TiHKAL • Info: A Visual Index and Map of TiHKAL: The Continuation by Alexander & Ann Shulgin
- Transform Press – Publisher of TiHKAL
Template:Tryptamines Template:Psychedelics Template:Chemical classes of psychoactive drugs